Literature DB >> 21226306

[Reversal of pulmonary hypertrophic osteoarthropathy in surgically treated lung cancer].

Yasuka Hara1, Yoshifumi Matsuura, Hiroto Takiguchi, Koken Ameku, Tadahisa Numakura, Takashi Horie, Muneo Minowa, Yuji Matsumura.   

Abstract

A 61-year-old man was admitted for evaluation of an abnormal chest abnormal with progressive swelling in both hands, clubbing of all fingers and toes, and polyarthroceles. He was given a diagnosis of pulmonary hypertrophic osteoarthropathy (PHO) associated with primary lung cancer, and underwent an upper left lobectomy. Histopathological analysis revealed stage IIB adenocarcinoma of the lung with K-ras mutation, but with no evidence of epidermal growth factor receptor (EGFR). Postoperatively, his symptoms rapidly improved, and the preoperatively observed high levels of serum vascular endothelial growth factor (VEGF) and interleukin 6 (IL-6) decreased to normal levels after just 1 month. VEGF and IL-6 caused by the genetic mutation of K-ras might play a role in the pathogenesis of PHO with lung cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21226306

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  2 in total

1.  Hypertrophic osteoarthropathy presenting as unilateral cellulitis with successful treatment using pamidronate disodium.

Authors:  Sebastian G Bernardo; Jason J Emer; Mark E Burnett; Marsha Gordon
Journal:  J Clin Aesthet Dermatol       Date:  2012-09

Review 2.  Small cell lung cancer with relapsing polychondritis: A report of one case and the review of literature.

Authors:  Yuan Liu; Ning Wang; Jian Xu; Ying Bi; Xue Han; Meng Dai; Chunfang Liu
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.